Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALIDATE-SWEDEHEART
NCT02311231Phase 4Completed
- Sponsor
- Uppsala University
- Start
- Jun 2014
- Primary completion
- Mar 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bivalirudin in ST-segment elevation myocardial infarction (STEMI), Non-ST-segment elevation myocardial infarction (NSTEMI), sponsored by Uppsala University. Started Jun 2014; status: completed.
02
Drugs
bivalirudin
03
Conditions
ST-segment elevation myocardial infarction (STEMI)Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT02311231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02311231.